The forecast for erythromycin imports to China shows a downward trend from 2024 to 2028, with values decreasing from 9.1 to 8.65 thousand kilograms. Compared to previous years, these figures indicate a steady decline in import volumes, reflecting a potential decrease in demand or an increase in domestic production. If the value stood at significantly higher levels in 2023, the percentage decreases year-on-year underscore strategic shifts in supply chains or regulatory changes.

Trends to watch for include:

The impact of increasing domestic erythromycin production on import demand.
Regulatory adjustments in China that could further influence import levels.
Global market dynamics, including cost fluctuations and supply chain disruptions, affecting availability and import strategies.